Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 216 | 36 | 178 |
| Samples | 204 | 34 | 168 |
| Peptides | 148 | 23 | 129 |
Function
RPA4 · Replication protein A4
This gene encodes a single-stranded DNA-binding protein that is the 30-kDa subunit of the replication protein A complex. Replication protein A is an essential factor for DNA double-strand break repair and cell cycle checkpoint activation. The encoded protein localizes to DNA repair foci and may be involved in the cellular DNA damage response. This protein may also play a role in inhibiting viral replication.[provided by RefSeq, Apr 2010].
Isoforms & Proteins
1 transcript · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000373040 | Q13156 | 216 | 148 |
Gene Properties
Recurrent Mutations
All 148 amino-acid changes on canonical ENST00000373040 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in RPA4 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in RPA4 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Acute Myeloid Leukemia | 2/90 2% | 0/0 0% |
| Endometrial Carcinoma | 3/42 7% | 8/612 1% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 2/133 2% |
| Non-Small Cell Lung Carcinoma | 8/304 3% | 13/1390 1% |
| Melanoma | 1/210 0% | 19/1899 1% |
| Other Sarcomas | 2/69 3% | 5/699 1% |
| Ovarian Carcinoma | 5/109 5% | 5/998 0% |
| Cervical Carcinoma | 0/35 0% | 4/422 1% |
| Small Cell Lung Carcinoma | 0/9 0% | 6/752 1% |
| Gastric Carcinoma | 1/74 1% | 13/1809 1% |
| Hodgkins Lymphoma | 0/16 0% | 1/122 1% |
| Colorectal Carcinoma | 4/143 3% | 20/3239 1% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 6/810 1% |
| Other Solid Cancers | 2/94 2% | 8/1515 1% |
| Plasma Cell Myeloma | 0/44 0% | 2/305 1% |
| Prostate Carcinoma | 0/13 0% | 11/2105 1% |
| Bladder Carcinoma | 0/58 0% | 5/956 1% |
| Non-Cancerous | 0/104 0% | 4/830 0% |
| Hepatocellular Carcinoma | 0/46 0% | 7/2210 0% |
| Head and Neck Carcinoma | 0/85 0% | 5/1574 0% |
| Breast Carcinoma | 2/144 1% | 7/3264 0% |
| Pancreatic Carcinoma | 0/89 0% | 4/1611 0% |
| Glioma | 0/52 0% | 5/2127 0% |
| Esophageal Squamous Cell Carcinoma | 1/51 2% | 3/2550 0% |
| Esophageal Carcinoma | 0/23 0% | 1/769 0% |
| Thyroid Gland Carcinoma | 0/45 0% | 2/1592 0% |
| B-Lymphoblastic Leukemia | 2/55 4% | 1/2640 0% |
| B-Cell Non-Hodgkins Lymphoma | 1/88 1% | 1/2534 0% |
| Neuroblastoma | 0/87 0% | 1/1331 0% |
| Kidney Carcinoma | 0/85 0% | 1/1862 0% |
Mutation Distribution
Where RPA4 is mutated · all tissues, split by cell line vs tissue
How many mutations in RPA4 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 52 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 216 mutations in RPA4
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|